Literature DB >> 2500756

Distribution of drugs over whole blood: I. The transport function of whole blood for valproate.

O Driessen1, L Treuren, J W Meijer.   

Abstract

A method is presented for the determination of valproate (VPA) in approximately 40 microliters erythrocyte concentrations. Valproate partition between plasma proteins, ultrafiltrate, and erythrocytes at various concentrations was studied in vitro and in vivo. Partition ratios depended on VPA concentration in whole blood and the ratio of erythrocytes/ultrafiltrate, which increased with rising concentrations in the ultrafiltrate fraction. Shifts in ratios were studied by expanding the ultrafiltrate fraction of VPA-spiked blood. It appeared that VPA delivery to the expanded ultrafiltrate compartment originated in a disproportionately large part from erythrocytes. In vivo the half-life of VPA in the erythrocyte fraction was 0.7 h, whereas in the ultrafiltrate fraction and protein-bound fraction half-lives of 2 and 5 h were observed. It is concluded that for VPA in relation to erythrocytes a "last-come-first-go" system is plausible.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500756

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  4 in total

1.  Volume-selective 1H MR spectroscopy for in vivo detection of valproate in patients with epilepsy.

Authors:  S Seyfert; J Bernarding; J Braun
Journal:  Neuroradiology       Date:  2003-03-27       Impact factor: 2.804

Review 2.  Erythrocytes and the transport of drugs and endogenous compounds.

Authors:  M S Highley; E A De Bruijn
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

3.  In vivo 1H magnetic resonance spectroscopy of rat brain after valproate administration.

Authors:  J Leib; J Braun; A Schilling; C Klingner; S Seyfert; W Vollmann; E Gedat; J Bernarding
Journal:  Neuroradiology       Date:  2004-03-25       Impact factor: 2.804

4.  Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy.

Authors:  Sing Teang Kong; Shih-Hui Lim; Wee Beng Lee; Pasikanthi Kishore Kumar; Hwee Yi Stella Wang; Yan Lam Shannon Ng; Pei Shieen Wong; Paul C Ho
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.